AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vogrus GM 1mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Cagrus Biopharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Vogrus GM 1mg/500mg/0.3mg Tablet

Diabeva Trio 1mg/500mg/0.3mg tablets are classified as anti-diabetic medications. This combination therapy treats type 2 diabetes in adults by regulating blood glucose. Diabeva Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and trembling. Learn to identify and manage these symptoms; maintain regular meals and carry a rapid-acting glucose source, like sugary snacks or juice. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Uses of Vogrus GM 1mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Vogrus GM 1mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Vogrus GM 1mg/500mg/0.3mg Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.

Common Side effects of Vogrus GM 1mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Vogrus GM 1mg/500mg/0.3mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogrus GM 1mg/500mg/0.3mg tablets should be administered on an empty stomach.

How Vogrus GM 1mg/500mg/0.3mg Tablet works:

Vogrus GM tablets, containing 1mg, 500mg, and 0.3mg of three distinct antidiabetic agents, offer a triple-action approach to blood sugar management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vogrus GM 1mg/500mg/0.3mg Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vogrus GM 1mg/500mg/0.3mg Tablet during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Vogrus GM 1mg/500mg/0.3mg Tablet while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyUNSAFE

The use of Vogrus GM 1mg/500mg/0.3mg Tablets is potentially hazardous for individuals with kidney impairment and should be strictly avoided. Medical advice is essential. Furthermore, its administration is discouraged in patients experiencing severe kidney dysfunction.

LiverLiverCAUTION

Exercise caution when prescribing Vogrus GM 1mg/500mg/0.3mg tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, initiate therapy with a reduced dose of Vogrus GM 1mg/500mg/0.3mg tablets; avoid use in those with severe liver disease.

What if you forget to take Vogrus GM 1mg/500mg/0.3mg Tablet :

Should you forget to take a Vogrus GM 1mg/500mg/0.3mg Tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vogrus GM 1mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vogrus GM 1mg/500mg/0.3mg Tablet

Vogrus GM, a combination tablet containing glimepiride, metformin, and voglibose, treats type 2 diabetes mellitus in adults. It improves blood glucose control when combined with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Vogrus GM 1mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, flatulence, abdominal pain, headache, rash, and respiratory infections.
Vogrus GM 1mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any ingredient or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Vogrus GM 1mg/500mg/0.3mg Tablet and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Vogrus GM 1mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Vogrus GM 1mg/500mg/0.3mg...
104
MRP 120
13% off